7. Which of the following has been shown to delay the need for mitral valve repair or replacement in the setting of severe mitral regurgitation?

A. Beta-blockers

B. Angiotensin converting enzyme inhibitors

C. Non-dihydropyridine calcium channel blockers

D. Hydralazine

E. None of the above
 

PROCEED TO ANSWER